STXS
$1.89
Stereotaxis, Inc.
Intraday
Recent News
Stereotaxis Inc (STXS) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Advances ...
Stereotaxis Inc (STXS) reports a 36% revenue increase in Q4 2025, driven by system sales and strategic product launches, despite facing manufacturing and transition challenges.
Stereotaxis Q4 Earnings Call Highlights
Stereotaxis (NYSEAMERICAN:STXS) executives used the company’s fourth-quarter and full-year 2025 earnings call to highlight a year of regulatory milestones, a shifting business model toward higher recurring revenue, and near-term execution priorities centered on manufacturing ramp-ups and early comme
Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates
Stereotaxis (STXS) delivered earnings and revenue surprises of +5.21% and -5.55%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Beats Revenue Estimates
Sight Sciences (SGHT) delivered earnings and revenue surprises of +44.83% and +0.34%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Can Digital Subscriptions Become ISRG's New Revenue Stream in 2026?
Intuitive Surgical's My Intuitive+ may turn paid in 2026, adding a software-driven revenue layer as renewals begin and digital engagement scales.